Cholesterol | Xconomy

by in

Entry	Blogger	Date	Location
Isis, Genzyme Cholesterol Drug Passes Test, But Investors Get Nervous About Liver Safety	Luke Timmerman	11/17/09	San Diego
Isis CEO Vows that Cholesterol Drug, Partnered With Genzyme, Will be “Remarkable” Advance	Luke Timmerman	10/21/09	San Diego
Oscient Pharma Seeks Bankruptcy, Finds Buyer for No. 2 Product	Ryan McBride	07/14/09	Boston
Genzyme, Isis Cholesterol Drug Reaches Goal in Pivotal Study, Paving the Way to FDA	Luke Timmerman	05/20/09	Boston
Genzyme, Isis Begin New Drug Trials	Ryan McBride	01/12/09	Boston
Genzyme Thinks Small, and Big, With Cholesterol-Lowering Drug Mipomersen	Luke Timmerman	09/29/08	Boston
Genzyme, Isis Start Pivotal Trial for High Cholesterol	Luke Timmerman	08/06/08	Boston
MediQuest Therapeutics Persuades FDA to Do 6-Month Review of Lead Product	Luke Timmerman	06/25/08	Seattle
Genzyme, Isis Finalize Partnership For Cholesterol-Lowering Drug	Luke Timmerman	06/24/08	Boston
Page 1 of 1

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, and beyond.